MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
0.8786
+0.0185
+2.15%
Closed 16:00 06/26 EDT
OPEN
0.8600
PREV CLOSE
0.8601
HIGH
0.9429
LOW
0.8600
VOLUME
72.91K
TURNOVER
--
52 WEEK HIGH
3.310
52 WEEK LOW
0.7101
MARKET CAP
4.56M
P/E (TTM)
-6.2757
1D
5D
1M
3M
1Y
5Y
1D
RedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role
TipRanks · 1d ago
RedHill Biopharma Closes $6 Million Private Placement to Fund Potential Acquisition
TipRanks · 4d ago
RedHill Biopharma Raises $6 Million in June 2026 Private Placement of ADSs and Warrants
TipRanks · 4d ago
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
PR Newswire · 4d ago
RedHill Biopharma Sets July 28, 2026 Shareholder Meeting to Vote on Board, CEO-Chairman Role
TipRanks · 4d ago
Weekly Report: what happened at RDHL last week (0615-0619)?
Weekly Report · 4d ago
RedHill Biopharma Secures Up to $19.4 Million in Private Placement to Fund Pipeline and Potential Acquisition
TipRanks · 06/18 12:26
RedHill Biopharma Commences ~$6M Offering Of American Depositary Shares, Series A-2 Warrants At $0.70/ADS
Benzinga · 06/18 12:05
More
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Webull offers RedHill Biopharma Ltd (ADR) stock information, including NASDAQ: RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.